Myriad Genetics, Inc., based in Salt Lake City, UT, specializes in cancer genomics, focusing on the development of innovative diagnostic tests that assess cancer risk and prognosis. The company is known for its expertise in cancer biomarkers and gene signatures, particularly in relation to hereditary cancer genes and homologous recombination deficiency. Myriad's technologies aid in identifying BRCA2 mutations and analyzing gene copy number profiling, contributing to personalized medicine and improved patient outcomes in oncology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

123 Patents

#7 in Salt Lake City, UT

#29 in Utah

#3,158 in US

#6,520 in the World

Salt Lake City, UT, United States of America

Myriad Genetics, Inc.

Forward Citations = 1,118

149 inventors:

Alexander Gutin (29 out of 34 patents)

Alexander Kamb (24 out of 25 patents)

Sean V Tavtigian (19 out of 26 patents)

4. Kirsten Timms (17 out of 17 patents)

5. Victor Abkevich (15 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Myriad Genetics, Inc.. Retrieved from https://idiyas.com/company/myriad-genetics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

20 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]